Novel Genes and Metabolite Trends in Bifidobacterium longum subsp. infantis Bi-26 Metabolism of Human Milk Oligosaccharide 2′-fucosyllactose
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel Genes and Metabolite Trends in Bifidobacterium longum subsp. infantis Bi-26 Metabolism of Human Milk Oligosaccharide 2′-fucosyllactose ; volume:9 ; number:1 ; day:28 ; month:5 ; year:2019 ; pages:1-11 ; date:12.2019
Scientific reports ; 9, Heft 1 (28.5.2019), 1-11, 12.2019
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Zabel, Bryan
Yde, Christian Clement
Roos, Paige
Marcussen, Jørn
Jensen, Henrik Max
Salli, Krista
Hirvonen, Johanna
Ouwehand, Arthur C.
Morovic, Wesley
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-43780-9
- URN
-
urn:nbn:de:101:1-2019110812174760961214
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zabel, Bryan
- Yde, Christian Clement
- Roos, Paige
- Marcussen, Jørn
- Jensen, Henrik Max
- Salli, Krista
- Hirvonen, Johanna
- Ouwehand, Arthur C.
- Morovic, Wesley
- SpringerLink (Online service)
Other Objects (12)
Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial
Transcriptomic analysis of Bifidobacterium longum subsp. longum BBMN68 in response to oxidative shock
O2-inducible H2O2-forming NADPH oxidase is responsible for the hyper O2 sensitivity of Bifidobacterium longum subsp. infantis
Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fatty acid production ex vivo
Longitudinal quantification of Bifidobacterium longum subsp. infantis reveals late colonization in the infant gut independent of maternal milk HMO composition
Improving the growth and stability following of lyophilized Bifidobacterium breve M4A and Bifidobacterium longum subsp. longum FA1 in skimmed milk media
Bifidobacterium longum subsp infantis (EVC001) is associated with reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies
Long-term colonization exceeding six years from early infancy of Bifidobacterium longum subsp. longum in human gut
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense
Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactisBl-04
Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial
Transcriptomic analysis of Bifidobacterium longum subsp. longum BBMN68 in response to oxidative shock
O2-inducible H2O2-forming NADPH oxidase is responsible for the hyper O2 sensitivity of Bifidobacterium longum subsp. infantis
Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fatty acid production ex vivo
Longitudinal quantification of Bifidobacterium longum subsp. infantis reveals late colonization in the infant gut independent of maternal milk HMO composition
Improving the growth and stability following of lyophilized Bifidobacterium breve M4A and Bifidobacterium longum subsp. longum FA1 in skimmed milk media
Bifidobacterium longum subsp infantis (EVC001) is associated with reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies
Long-term colonization exceeding six years from early infancy of Bifidobacterium longum subsp. longum in human gut
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense
Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactisBl-04
Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial
Transcriptomic analysis of Bifidobacterium longum subsp. longum BBMN68 in response to oxidative shock
O2-inducible H2O2-forming NADPH oxidase is responsible for the hyper O2 sensitivity of Bifidobacterium longum subsp. infantis
Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fatty acid production ex vivo
Longitudinal quantification of Bifidobacterium longum subsp. infantis reveals late colonization in the infant gut independent of maternal milk HMO composition
Improving the growth and stability following of lyophilized Bifidobacterium breve M4A and Bifidobacterium longum subsp. longum FA1 in skimmed milk media
Bifidobacterium longum subsp infantis (EVC001) is associated with reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies
Long-term colonization exceeding six years from early infancy of Bifidobacterium longum subsp. longum in human gut
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense
Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial